Keudell Altimmune, Inc. Transaction History
Keudell
- $422 Million
- Q2 2025
A detailed history of Keudell transactions in Altimmune, Inc. stock. As of the latest transaction made, Keudell holds 16,360 shares of ALT stock, worth $59,223. This represents 0.01% of its overall portfolio holdings.
Number of Shares
16,360Holding current value
$59,223% of portfolio
0.01%Shares
3 transactions
Others Institutions Holding ALT
# of Institutions
213Shares Held
38.1MCall Options Held
2.28MPut Options Held
1.83M-
Black Rock Inc. New York, NY5.32MShares$19.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.17MShares$18.7 Million0.0% of portfolio
-
State Street Corp Boston, MA3.39MShares$12.3 Million0.0% of portfolio
-
Tang Capital Management LLC San Diego, CA2.75MShares$9.96 Million0.89% of portfolio
-
Geode Capital Management, LLC Boston, MA1.93MShares$7 Million0.0% of portfolio
About Altimmune, Inc.
- Ticker ALT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 49,025,300
- Market Cap $177M
- Description
- Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity and liver diseases. The company's lead product candidate, pemvidutide (proposed INN, formerly known as ALT-801), is a GLP-1/glucagon dual receptor agonist that is in Phase 1b trial for the treatment of obesity and non-alcoholic steatohepatit...